4/A//SEC Filing
Flaa Mickael 4/A
Accession 0001303497-05-000028
CIK 0001303497other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 5:22 PM ET
Size
8.2 KB
Accession
0001303497-05-000028
Insider Transaction Report
Form 4/AAmended
Flaa Mickael
DirectorDirector, Chief Financial Off.
Transactions
- Other
Warrant (Right to Buy)
2005-08-17$2.00/sh+200,000$400,000→ 250,000 totalExercise: $2.00From: 2003-06-23Exp: 2013-06-23→ Common stock (200,000 underlying) - Award
Nonstatutory Stock Option (Right to Buy)
2005-08-17$10.00/sh+50,000$500,000→ 50,000 totalExercise: $10.00From: 2005-08-17Exp: 2015-08-17→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Option grant pursuant to stock plan registered on Form S-8 and approved by the Board of Directors and thus such transaction and purchases pursuant to exercises of this option are exempt from Section 16b-3(d)(1).
- [F2]For services rendered
Documents
Issuer
CardioVascular BioTherapeutics, Inc.
CIK 0001303497
Entity typeother
Related Parties
1- filerCIK 0001314768
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 5:22 PM ET
- Size
- 8.2 KB